Not the point I was making. If this drug is proven

Not the point I was making. If this drug is proven by scan to have antitumor efficacy - the first place we would find about about such remarkable news would not be in an email to an investor. And Andrew is not the pr spokesperson for the team. If this announcement were going to be made by the team, it would only be made by DrShapiro. And that is unlikley, because it is Leo's to make. Really no one elses.

And in these IND cancer studies, first cohort continuation is common just on lack of toxicity. That IS meaningful in itself. If drug looks as though no harm being caused, fda allows continuation. Even escalation of first cohort is allowed - again, if no toxicity - because these people have nothing to lose. They've failed everything else. And the continued lack of toxicity itself is a huge reason to keep them going - the more data the better.

So - point is - this drug could be curing tumors for all I know - and that potential is why I'm here - but we did not get notice from DF research team today that that is so. Or if we did...someones head is on the chopping block!